
Helen of Troy Limited ($HELE) reported its Q3 FY2025 earnings, revealing consolidated net sales revenue of $530.7 million, a 3.4% decline from the previous year. The company posted a GAAP diluted earnings per share (EPS) of $2.17, down from $3.19, while its non-GAAP adjusted diluted EPS was $2.67, exceeding analysts' expectations of $2.60. Revenue also surpassed estimates, coming in at $530.71 million compared to the forecast of $534.31 million. Despite these results, Helen of Troy's shares fell by 3.86% in pre-market trading, reflecting concerns over weakening sales and revised guidance. The gross profit margin improved by 90 basis points to 48.9%, attributed to cost efficiencies and the company's Project Pegasus initiative. Net income for the quarter stood at $49.62 million.
Really, this Q is just $HELE being HELE. The company is structurally broken. Not investing enough to prevent a melt down in the core, while it overpays for 'average' assets, and tries to make up for it with creative accounting. Best Idea Short -- the gift that will forever give…
$RCEL (-23.2% pre) AVITA Medical stock slides on lowered guidance - SA https://t.co/pwD5lSuwga
$HELE (-4.3% pre) Helen of Troy shares defensive on weakening sales, revised guidance - SA https://t.co/ojds3K6crI